WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹19 Cr | ₹-52 Cr | ₹-198 Cr | ₹-189 Cr | ₹-258 Cr |
What is the latest Net Current Assets ratio of WANBURY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹-52 Cr |
| Mar2023 | ₹-198 Cr |
| Mar2022 | ₹-189 Cr |
| Mar2021 | ₹-258 Cr |
How is Net Current Assets of WANBURY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | Positive | |
| Mar2024 | ₹-52 Cr | Negative | |
| Mar2023 | ₹-198 Cr | Negative | |
| Mar2022 | ₹-189 Cr | Negative | |
| Mar2021 | ₹-258 Cr | - | |
Compare Net Current Assets of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹872.3 Cr | -5% | -0.3% | 36.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -5% |
-0.3% |
36.4% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses